Shattuck Labs (STTK) Financials

Shattuck Labs logo
$4.59 -0.07 (-1.50%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$4.88 +0.30 (+6.43%)
As of 07:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Shattuck Labs

Annual Income Statements for Shattuck Labs

This table shows Shattuck Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-24 -37 -45 -102 -87 -75 -49
Consolidated Net Income / (Loss)
-24 -37 -45 -102 -87 -75 -49
Net Income / (Loss) Continuing Operations
-24 -36 -45 -102 -87 -75 -49
Total Pre-Tax Income
-24 -37 -45 -102 -87 -75 -49
Total Operating Income
-25 -37 -45 -103 -92 -81 -52
Total Gross Profit
9.89 9.93 30 0.65 1.66 5.72 1.00
Total Revenue
9.89 9.93 30 0.65 1.66 5.72 1.00
Operating Revenue
9.89 9.93 30 0.65 1.66 5.72 1.00
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
35 47 75 104 94 86 53
Selling, General & Admin Expense
5.74 9.38 19 21 19 19 17
Research & Development Expense
29 37 57 83 74 67 35
Total Other Income / (Expense), net
1.09 0.33 0.30 1.38 4.66 5.16 2.70
Interest & Investment Income
1.18 0.55 0.63 1.59 4.67 5.17 2.70
Other Income / (Expense), net
-0.10 -0.22 -0.33 -0.21 -0.01 -0.02 -0.00
Basic Earnings per Share
($3.17) ($2.36) ($1.07) ($2.41) ($2.05) ($1.49) ($0.70)
Weighted Average Basic Shares Outstanding
7.56M 15.51M 42.03M 42.38M 42.60M 50.76M 69.58M
Diluted Earnings per Share
($3.17) ($2.36) ($1.07) ($2.41) ($2.05) ($1.49) ($0.70)
Weighted Average Diluted Shares Outstanding
7.56M 15.51M 42.03M 42.38M 42.60M 50.76M 69.58M
Weighted Average Basic & Diluted Shares Outstanding
7.56M 15.51M 42.36M 42.45M 47.47M 47.90M 71.56M

Quarterly Income Statements for Shattuck Labs

This table shows Shattuck Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Total Costs & Expenses
- - - - - - 12 - - - 27
Net Income / (Loss) Attributable to Common Shareholders
-19 -22 -17 -19 -14 -12 -10 -13 -15 -15 -25
Consolidated Net Income / (Loss)
-19 -22 -17 -19 -14 -12 -10 -13 -15 -15 -25
Net Income / (Loss) Continuing Operations
-19 -22 -17 -19 -14 -12 -10 -13 -15 -15 -25
Total Pre-Tax Income
-19 -22 -17 -19 -14 -12 -10 -13 -15 -15 -25
Total Operating Income
-20 -23 -18 -20 -14 -13 -11 -13 -16 -16 -27
Total Gross Profit
1.12 1.61 3.00 - 0.00 0.00 1.00 - 0.00 0.00 0.00
Total Revenue
1.12 1.61 3.00 - 0.00 0.00 1.00 - 0.00 0.00 0.00
Operating Revenue
1.12 1.61 3.00 - 0.00 0.00 1.00 - 0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Operating Expenses
21 25 21 20 14 13 12 13 16 16 27
Selling, General & Admin Expense
4.90 5.33 4.60 4.25 4.47 4.35 4.10 4.32 4.60 4.46 5.48
Research & Development Expense
16 19 16 15 9.92 8.68 7.62 9.06 11 12 22
Total Other Income / (Expense), net
1.54 1.41 1.25 0.96 0.69 0.57 0.66 0.78 0.78 1.00 1.84
Interest & Investment Income
- - - - 0.69 0.80 0.67 - 0.78 1.03 1.86
Other Income / (Expense), net
1.54 1.41 1.25 -4.21 -0.00 -0.23 -0.01 -1.93 -0.00 -0.03 -0.01
Basic Earnings per Share
($0.37) ($0.42) ($0.33) ($0.37) ($0.27) ($0.24) ($0.14) ($0.05) ($0.13) ($0.12) ($0.14)
Weighted Average Basic Shares Outstanding
50.57M 50.79M 50.83M 50.76M 50.97M 51.00M 72.18M 69.58M 112.23M 129.78M 183.22M
Diluted Earnings per Share
($0.37) ($0.42) ($0.33) ($0.37) ($0.27) ($0.24) ($0.14) ($0.05) ($0.13) ($0.12) ($0.14)
Weighted Average Diluted Shares Outstanding
50.57M 50.79M 50.83M 50.76M 50.97M 51.00M 72.18M 69.58M 112.23M 129.78M 183.22M
Weighted Average Basic & Diluted Shares Outstanding
47.55M 47.73M 47.74M 47.90M 47.90M 47.90M 63.28M 71.56M 76.68M 100.36M 101.84M

Annual Cash Flow Statements for Shattuck Labs

This table details how cash moves in and out of Shattuck Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-25 151 -66 -45 78 -68 -3.20
Net Cash From Operating Activities
-21 -34 -57 -94 -81 -61 -40
Net Cash From Continuing Operating Activities
-21 -34 -57 -94 -81 -61 -40
Net Income / (Loss) Continuing Operations
-24 -37 -45 -102 -87 -75 -49
Consolidated Net Income / (Loss)
-24 -37 -45 -102 -87 -75 -49
Depreciation Expense
0.54 0.62 1.38 3.07 4.04 3.83 3.69
Amortization Expense
- 0.00 3.04 1.37 -1.48 -2.15 -0.45
Non-Cash Adjustments To Reconcile Net Income
0.30 1.27 5.47 7.47 7.61 10 6.48
Changes in Operating Assets and Liabilities, net
2.18 1.06 -22 -4.46 -4.10 3.02 -0.79
Net Cash From Investing Activities
-3.59 -146 -10 49 111 -8.51 -7.89
Net Cash From Continuing Investing Activities
-3.59 -146 -10 49 111 -8.51 -7.89
Purchase of Property, Plant & Equipment
-0.47 -0.73 -7.93 -12 -0.41 -0.06 -0.07
Purchase of Investments
-44 -183 -204 -132 -80 -94 -43
Sale and/or Maturity of Investments
41 38 202 193 191 85 36
Net Cash From Financing Activities
-0.06 331 1.93 0.17 49 0.79 45
Net Cash From Continuing Financing Activities
-0.06 331 1.93 0.17 49 0.79 45
Repurchase of Common Equity
-0.06 -19 - - - -0.02 0.00
Issuance of Common Equity
0.00 233 1.93 0.17 49 1.26 45
Other Financing Activities, net
0.00 - - 0.00 -0.05 -0.45 0.07

Quarterly Cash Flow Statements for Shattuck Labs

This table details how cash moves in and out of Shattuck Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-44 -21 -17 14 3.51 -10 -7.92 12 36 -27 -1.54
Net Cash From Operating Activities
-16 -11 -16 -17 -12 -10 -8.93 -8.49 -13 -10 -17
Net Cash From Continuing Operating Activities
-11 -16 -16 -17 -12 -10 -8.93 -8.49 -13 -10 -17
Net Income / (Loss) Continuing Operations
-19 -22 -17 -19 -14 -12 -10 -13 -15 -15 -25
Consolidated Net Income / (Loss)
-19 -22 -17 -19 -14 -12 -10 -13 -15 -15 -25
Depreciation Expense
0.97 0.96 0.95 0.94 0.94 0.93 0.92 0.91 0.89 0.85 0.81
Amortization Expense
-0.37 -0.62 -0.74 -0.42 -0.00 0.00 -0.17 -0.29 -0.05 -0.20 -1.33
Non-Cash Adjustments To Reconcile Net Income
2.58 2.77 2.81 2.04 1.48 2.01 0.85 1.77 2.55 2.18 4.23
Changes in Operating Assets and Liabilities, net
4.54 2.14 -2.41 -1.25 -0.86 -0.92 -0.48 1.71 -2.05 2.13 4.01
Net Cash From Investing Activities
-33 -5.41 -0.82 31 16 - -43 20 24 -145 12
Net Cash From Continuing Investing Activities
-33 -5.41 -0.82 31 16 - -43 20 24 -145 12
Purchase of Property, Plant & Equipment
- - -0.04 - 0.00 - -0.07 - - - -0.05
Purchase of Investments
-38 -25 -30 - 0.00 - -43 - -0.07 -145 -30
Sale and/or Maturity of Investments
5.00 20 29 31 16 - - 20 24 -0.00 42
Net Cash From Financing Activities
-0.18 1.02 0.02 -0.07 -0.06 - 44 0.13 26 128 4.20
Net Cash From Continuing Financing Activities
-0.18 1.02 0.02 -0.07 -0.06 - 44 0.13 26 128 4.20
Issuance of Common Equity
0.61 0.67 0.04 -0.07 0.01 - 44 -0.01 21 81 0.04
Other Financing Activities, net
-0.44 -0.01 -0.00 - -0.07 - - 0.14 5.18 47 4.17

Annual Balance Sheets for Shattuck Labs

This table presents Shattuck Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
45 349 299 205 160 91 91
Total Current Assets
42 346 288 185 143 79 82
Cash & Equivalents
7.01 158 92 47 126 57 54
Short-Term Investments
32 178 177 114 5.00 16 24
Prepaid Expenses
3.36 10 19 23 13 6.23 4.41
Plant, Property, & Equipment, net
2.44 3.00 9.94 18 14 9.81 6.11
Total Noncurrent Assets
0.09 0.35 0.38 3.07 2.54 2.02 2.44
Long-Term Investments
- - - - - 0.00 1.00
Other Noncurrent Operating Assets
0.09 0.35 0.38 3.07 2.54 2.02 1.44
Total Liabilities & Shareholders' Equity
45 349 299 205 160 91 91
Total Liabilities
30 39 27 29 15 11 8.64
Total Current Liabilities
20 17 25 25 11 8.92 7.05
Accounts Payable
3.05 1.75 10 7.17 1.59 2.42 2.10
Accrued Expenses
4.04 7.35 15 18 9.87 6.50 4.95
Total Noncurrent Liabilities
10 22 2.21 4.20 3.41 2.51 1.58
Other Noncurrent Operating Liabilities
- - 0.00 4.20 3.41 2.51 1.58
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-35 310 272 176 145 80 82
Total Preferred & Common Equity
-35 310 272 176 145 80 82
Total Common Equity
-35 310 272 176 145 80 82
Common Stock
0.89 382 389 396 451 461 513
Retained Earnings
-35 -72 -117 -219 -306 -382 -431
Accumulated Other Comprehensive Income / (Loss)
0.05 -0.06 -0.56 -0.88 0.00 0.00 0.01

Quarterly Balance Sheets for Shattuck Labs

This table presents Shattuck Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
130 146 129 112 77 64 100 102 221 208
Total Current Assets
113 131 114 99 66 55 91 94 213 202
Cash & Equivalents
41 76 61 44 61 50 43 90 63 62
Short-Term Investments
60 39 45 46 0.00 0.00 44 0.00 145 135
Prepaid Expenses
12 16 9.08 8.68 5.51 4.21 4.59 3.33 4.97 5.29
Plant, Property, & Equipment, net
15 13 12 11 8.88 7.95 7.05 5.35 4.51 3.63
Total Noncurrent Assets
2.67 2.43 2.29 2.15 1.89 1.75 2.56 3.02 2.88 2.74
Long-Term Investments
- - - - - - - 1.00 1.00 1.00
Other Noncurrent Operating Assets
2.67 2.43 2.29 2.15 1.89 1.75 2.56 2.02 1.88 1.74
Total Liabilities & Shareholders' Equity
130 146 129 112 77 64 100 102 221 208
Total Liabilities
18 18 18 15 9.58 7.35 7.09 6.29 9.53 14
Total Current Liabilities
14 14 15 12 7.32 5.34 5.34 4.25 7.73 13
Accounts Payable
2.02 2.15 2.82 2.93 1.53 0.48 1.16 1.25 3.94 3.92
Accrued Expenses
12 7.57 9.21 9.47 5.78 4.86 4.17 3.00 3.79 8.84
Total Noncurrent Liabilities
3.62 3.19 2.97 2.74 2.27 2.02 1.76 2.04 1.80 1.56
Other Noncurrent Operating Liabilities
3.62 3.19 2.97 2.74 2.27 2.02 1.76 2.04 1.80 1.56
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
113 129 111 97 68 57 93 96 211 194
Total Preferred & Common Equity
113 129 111 97 68 57 93 96 211 194
Total Common Equity
113 129 111 97 68 57 93 96 211 194
Common Stock
401 454 457 460 463 465 511 541 672 679
Retained Earnings
-289 -325 -346 -363 -395 -408 -418 -445 -460 -486
Accumulated Other Comprehensive Income / (Loss)
0.01 -0.01 -0.01 0.05 0.00 0.00 0.00 0.00 -0.06 -0.06

Annual Metrics And Ratios for Shattuck Labs

This table displays calculated financial ratios and metrics derived from Shattuck Labs' official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 41,744,237.00 42,246,539.00 42,390,586.00 42,485,485.00 47,739,708.00 63,279,843.00
DEI Adjusted Shares Outstanding
0.00 41,744,237.00 42,246,539.00 42,390,586.00 42,485,485.00 47,739,708.00 63,279,843.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -0.88 -1.06 -2.40 -2.05 -1.58 -0.77
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 0.48% 202.16% -97.83% 154.14% 245.26% -82.52%
EBITDA Growth
0.00% -48.33% -12.73% -140.61% 9.77% 11.75% 38.82%
EBIT Growth
0.00% -47.63% -22.74% -127.06% 11.17% 12.38% 36.08%
NOPAT Growth
0.00% -47.33% -22.58% -128.26% 11.01% 12.39% 36.07%
Net Income Growth
0.00% -52.63% -22.87% -126.68% 14.37% 13.62% 35.28%
EPS Growth
0.00% 25.55% 54.66% -125.23% 14.94% 27.32% 53.02%
Operating Cash Flow Growth
0.00% -60.47% -69.69% -65.45% 14.04% 25.50% 34.10%
Free Cash Flow Firm Growth
0.00% 0.00% -142.64% -39.77% 24.52% 22.99% 33.12%
Invested Capital Growth
0.00% -4.14% 111.65% 398.89% -5.36% -52.85% -49.92%
Revenue Q/Q Growth
0.00% 0.00% 2,243.25% -97.85% 24.31% -11.10% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 35.45% -57.21% 4.62% -1.98% 15.21%
EBIT Q/Q Growth
0.00% 0.00% 29.75% -49.38% 4.81% -1.89% 14.25%
NOPAT Q/Q Growth
0.00% 0.00% 31.95% -52.39% 7.38% -0.86% 10.85%
Net Income Q/Q Growth
0.00% 0.00% 30.63% -48.42% 8.13% -1.33% 11.09%
EPS Q/Q Growth
0.00% 0.00% -167.50% -47.85% 8.48% 2.61% 31.37%
Operating Cash Flow Q/Q Growth
0.00% -23.58% -8.91% -5.73% 5.16% 3.28% 18.21%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 7.26% 4.98% 3.49% 20.21%
Invested Capital Q/Q Growth
0.00% 0.00% 110.27% 4.01% 20.25% 1.84% -53.22%
Profitability Metrics
- - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-249.10% -367.76% -137.20% -15,198.47% -5,395.78% -1,379.23% -4,827.70%
Operating Margin
-253.53% -371.76% -150.81% -15,848.01% -5,549.61% -1,408.27% -5,150.80%
EBIT Margin
-254.54% -373.99% -151.91% -15,879.91% -5,550.21% -1,408.56% -5,151.20%
Profit (Net Income) Margin
-242.56% -368.46% -149.83% -15,635.74% -5,268.44% -1,318.13% -4,880.90%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
95.30% 98.52% 98.63% 98.46% 94.92% 93.58% 94.75%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% -810.02% -444.59% -544.40% -723.72%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% -796.24% -428.88% -525.72% -706.94%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 764.50% 390.17% 477.17% 663.47%
Return on Equity (ROE)
-165.21% -22.57% -15.46% -45.52% -54.41% -67.23% -60.25%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -2,020.73% -943.23% -439.08% -472.57% -657.20%
Operating Return on Assets (OROA)
-55.96% -18.86% -14.08% -41.09% -50.41% -64.31% -56.58%
Return on Assets (ROA)
-53.33% -18.58% -13.89% -40.46% -47.85% -60.18% -53.61%
Return on Common Equity (ROCE)
393.20% -19.15% -15.46% -45.52% -54.41% -67.23% -60.25%
Return on Equity Simple (ROE_SIMPLE)
69.42% -11.81% -16.55% -57.87% -60.33% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-18 -26 -32 -72 -64 -56 -36
NOPAT Margin
-177.47% -260.23% -105.57% -11,093.60% -3,884.73% -985.79% -3,605.56%
Net Nonoperating Expense Percent (NNEP)
-16.46% -5.74% -4.40% -13.77% -15.71% -18.68% -16.78%
Return On Investment Capital (ROIC_SIMPLE)
- - - - -44.48% -70.83% -43.76%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
58.02% 94.44% 62.37% 3,233.44% 1,165.00% 333.46% 1,723.50%
R&D to Revenue
295.52% 377.32% 188.44% 12,714.57% 4,484.61% 1,174.81% 3,527.30%
Operating Expenses to Revenue
353.53% 471.76% 250.81% 15,948.01% 5,649.61% 1,508.27% 5,250.80%
Earnings before Interest and Taxes (EBIT)
-25 -37 -46 -104 -92 -81 -52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-25 -37 -41 -99 -89 -79 -48
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 7.06 1.32 0.55 2.09 0.73 2.80
Price to Tangible Book Value (P/TBV)
0.00 7.06 1.32 0.55 2.09 0.73 2.80
Price to Revenue (P/Rev)
17.19 220.24 11.98 149.54 182.81 10.10 230.97
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 30.42 0.00 12.24 0.00 45.69
Enterprise Value to Revenue (EV/Rev)
18.20 186.47 3.02 0.00 103.98 0.00 151.91
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-2.69 -1.15 -1.04 -0.96 -0.91 -0.91 -0.94
Leverage Ratio
3.10 1.21 1.11 1.12 1.14 1.12 1.12
Compound Leverage Factor
2.95 1.20 1.10 1.11 1.08 1.05 1.06
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
338.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-238.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
1.22 34.07 8.16 -0.22 8.64 -4.77 8.56
Noncontrolling Interest Sharing Ratio
338.00% 15.13% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - -
Current Ratio
2.12 20.53 11.72 7.39 12.51 8.88 11.70
Quick Ratio
1.96 19.93 10.93 6.46 11.41 8.19 11.07
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -25 -60 -84 -64 -49 -33
Operating Cash Flow to CapEx
-4,462.77% -4,629.85% -720.62% -821.01% -19,957.74% -102,567.80% -56,171.83%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.22 0.05 0.09 0.00 0.01 0.05 0.01
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
4.06 3.65 4.64 0.05 0.11 0.48 0.13
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - -
Invested Capital
-25 -26 2.98 15 14 6.64 3.33
Invested Capital Turnover
-0.40 -0.40 -2.66 0.07 0.11 0.55 0.20
Increase / (Decrease) in Invested Capital
0.00 -1.02 29 12 -0.80 -7.44 -3.31
Enterprise Value (EV)
180 1,852 91 -64 172 -15 152
Market Capitalization
170 2,188 360 97 303 58 231
Book Value per Share
($4.57) $7.42 $6.43 $4.16 $3.41 $1.67 $1.30
Tangible Book Value per Share
($4.57) $7.42 $6.43 $4.16 $3.41 $1.67 $1.30
Total Capital
15 310 272 176 145 80 82
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-39 -335 -269 -161 -131 -73 -79
Capital Expenditures (CapEx)
0.47 0.73 7.93 12 0.41 0.06 0.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-17 -6.64 -5.12 -1.66 1.14 -2.69 -2.64
Debt-free Net Working Capital (DFNWC)
22 329 264 160 132 70 75
Net Working Capital (NWC)
22 329 264 160 132 70 75
Net Nonoperating Expense (NNE)
6.44 11 13 30 23 19 13
Net Nonoperating Obligations (NNO)
-39 -335 -269 -161 -131 -73 -79
Total Depreciation and Amortization (D&A)
0.54 0.62 4.42 4.44 2.56 1.68 3.24
Debt-free, Cash-free Net Working Capital to Revenue
-168.19% -66.88% -17.07% -254.75% 68.92% -47.00% -264.20%
Debt-free Net Working Capital to Revenue
227.15% 3,309.90% 878.44% 24,481.44% 7,952.14% 1,228.77% 7,542.30%
Net Working Capital to Revenue
227.15% 3,309.90% 878.44% 24,481.44% 7,952.14% 1,228.77% 7,542.30%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 ($2.36) ($1.07) ($2.41) ($2.05) ($1.49) ($0.70)
Adjusted Weighted Average Basic Shares Outstanding
0.00 41.78M 42.03M 42.38M 42.60M 50.76M 69.58M
Adjusted Diluted Earnings per Share
$0.00 ($2.36) ($1.07) ($2.41) ($2.05) ($1.49) ($0.70)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 41.78M 42.03M 42.38M 42.60M 50.76M 69.58M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($2.36) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 15.51M 42.36M 42.45M 47.47M 47.90M 71.56M
Normalized Net Operating Profit after Tax (NOPAT)
-18 -26 -32 -72 -64 -56 -36
Normalized NOPAT Margin
-177.47% -260.23% -105.57% -11,093.60% -3,884.73% -985.79% -3,605.56%
Pre Tax Income Margin
-242.56% -368.46% -149.83% -15,635.74% -5,268.44% -1,318.13% -4,880.90%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-0.27% -52.68% 0.00% 0.00% 0.00% -0.02% 0.00%

Quarterly Metrics And Ratios for Shattuck Labs

This table displays calculated financial ratios and metrics derived from Shattuck Labs' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
47,474,783.00 47,550,872.00 47,727,269.00 47,739,708.00 47,899,240.00 47,899,240.00 47,903,215.00 63,279,843.00 71,564,217.00 76,680,517.00 100,363,253.00
DEI Adjusted Shares Outstanding
47,474,783.00 47,550,872.00 47,727,269.00 47,739,708.00 47,899,240.00 47,899,240.00 47,903,215.00 63,279,843.00 71,564,217.00 76,680,517.00 100,363,253.00
DEI Earnings Per Adjusted Shares Outstanding
-0.39 -0.45 -0.35 -0.39 -0.29 -0.26 -0.21 -0.20 -0.21 -0.20 -0.25
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1,856.14% 704.50% 336.88% 0.00% -100.00% -100.00% -66.63% 0.00% 0.00% 0.00% -100.00%
EBITDA Growth
10.15% -2.90% 39.18% -7.02% 24.83% 45.64% 43.48% 37.10% -9.26% -25.89% -176.28%
EBIT Growth
10.71% -0.97% 39.45% -6.70% 22.23% 42.20% 39.69% 35.87% -8.03% -22.01% -152.17%
NOPAT Growth
7.47% -0.95% 37.34% -3.64% 28.21% 43.25% 40.20% 31.92% -8.03% -23.96% -152.39%
Net Income Growth
10.71% -0.97% 39.45% -5.61% 25.95% 42.20% 39.69% 32.58% -7.77% -21.62% -150.63%
EPS Growth
24.49% 16.00% 49.23% 9.76% 27.03% 42.86% 57.58% 86.49% 51.85% 50.00% 0.00%
Operating Cash Flow Growth
38.93% 41.35% 3.98% 10.55% 25.55% 4.46% 44.42% 51.12% -11.57% 2.36% -95.65%
Free Cash Flow Firm Growth
63.48% 99.79% 57.79% 49.41% 71.35% -17,412.46% -10.01% 4.15% -233.66% 36.65% -1.05%
Invested Capital Growth
-26.17% -75.23% -44.32% -52.85% -52.84% 24.28% 9.04% -49.92% -33.97% -72.02% -151.34%
Revenue Q/Q Growth
56.16% 44.30% 86.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
17.90% -18.47% 22.37% -41.73% 42.33% 9.71% 19.28% -57.72% -0.18% -5.59% -77.58%
EBIT Q/Q Growth
17.23% -16.47% 22.63% -43.05% 39.67% 9.08% 19.28% -52.11% -1.63% -4.08% -67.22%
NOPAT Q/Q Growth
-5.77% -14.56% 21.96% -9.60% 26.74% 9.43% 17.77% -24.78% -16.26% -3.92% -67.42%
Net Income Q/Q Growth
-4.62% -16.47% 22.63% -12.02% 26.64% 9.08% 19.28% -25.23% -17.26% -2.61% -66.33%
EPS Q/Q Growth
9.76% -13.51% 21.43% -12.12% 27.03% 11.11% 41.67% 64.29% -160.00% 7.69% -16.67%
Operating Cash Flow Q/Q Growth
16.78% 32.44% -47.15% -8.12% 30.73% 13.31% 14.40% 4.92% -58.12% 24.13% -71.53%
Free Cash Flow Firm Q/Q Growth
27.78% 99.34% -12,280.47% 14.23% 59.09% -303.15% 22.23% 25.27% -42.41% 23.46% -24.06%
Invested Capital Q/Q Growth
0.71% -62.82% 23.65% 1.84% 0.74% -2.03% 8.49% -53.22% 32.81% -58.49% -299.07%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 100.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin
-1,605.47% -1,318.02% -549.35% 0.00% 0.00% 0.00% -930.50% 0.00% 0.00% 0.00% 0.00%
Operating Margin
-1,797.67% -1,427.10% -597.93% 0.00% 0.00% 0.00% -1,071.60% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
-1,659.55% -1,339.47% -556.39% 0.00% 0.00% 0.00% -1,005.60% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
-1,659.55% -1,339.47% -556.39% 0.00% 0.00% 0.00% -1,005.60% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 78.31% 95.21% 100.00% 100.00% 82.33% 94.99% 93.64% 93.14%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-204.66% -310.25% -295.52% 0.00% 0.00% 0.00% -110.09% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-201.13% -305.32% -291.20% 0.00% 0.00% 0.00% -107.19% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
177.69% 272.77% 265.85% 0.00% 0.00% 0.00% 99.50% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-26.98% -37.48% -29.68% 0.00% 0.00% 0.00% -10.60% 0.00% 0.00% 0.00% -47.20%
Cash Return on Invested Capital (CROIC)
-348.72% -356.76% -556.55% -472.57% -430.77% -791.06% -602.24% -657.20% -623.07% -818.89% 0.00%
Operating Return on Assets (OROA)
-27.81% -38.92% -29.57% 0.00% 0.00% 0.00% -9.48% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
-27.81% -38.92% -29.57% 0.00% 0.00% 0.00% -9.48% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-26.98% -37.48% -29.68% 0.00% 0.00% 0.00% -10.60% 0.00% 0.00% 0.00% -47.20%
Return on Equity Simple (ROE_SIMPLE)
-66.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-14 -16 -13 -14 -10 -9.12 -7.50 -9.36 -11 -11 -19
NOPAT Margin
-1,258.37% -998.97% -418.55% 0.00% 0.00% 0.00% -750.12% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-3.54% -4.92% -4.32% -4.84% -4.14% -4.28% -2.90% -4.25% -5.10% -2.96% -4.42%
Return On Investment Capital (ROIC_SIMPLE)
-10.89% -14.53% -12.99% -17.27% -14.90% -16.00% -8.05% -11.36% -11.35% -5.36% -9.78%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
439.01% 331.39% 153.62% 0.00% 0.00% 0.00% 409.80% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
1,458.65% 1,195.71% 544.31% 0.00% 0.00% 0.00% 761.80% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
1,897.67% 1,527.10% 697.93% 0.00% 0.00% 0.00% 1,171.60% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-19 -22 -17 -24 -14 -12 -10 -15 -16 -16 -27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-18 -21 -16 -23 -13 -12 -9.31 -15 -15 -16 -28
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.29 1.66 1.72 0.73 0.67 0.67 1.23 2.80 4.80 2.52 3.53
Price to Tangible Book Value (P/TBV)
3.29 1.66 1.72 0.73 0.67 0.67 1.23 2.80 4.80 2.52 3.53
Price to Revenue (P/Rev)
156.33 44.51 25.88 10.10 9.88 12.65 114.49 230.97 460.16 532.16 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
21.85 14.83 11.74 0.00 0.00 0.00 3.99 45.69 83.50 176.14 0.00
Enterprise Value to Revenue (EV/Rev)
114.10 18.96 11.89 0.00 0.00 0.00 28.36 151.91 368.74 322.86 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.88 -0.89 -0.91 -0.91 -0.89 -0.93 -0.93 -0.94 -0.93 -0.97 -0.99
Leverage Ratio
1.13 1.14 1.16 1.12 1.14 1.15 1.12 1.12 1.10 1.06 1.07
Compound Leverage Factor
1.13 1.14 1.16 0.87 1.08 1.15 1.12 0.93 1.04 1.00 1.00
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
11.98 2.76 2.54 -2.71 -3.96 -5.45 4.55 9.88 38.38 31.46 26.08
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
9.15 7.62 7.96 8.88 9.08 10.25 17.00 11.70 22.06 27.59 15.80
Quick Ratio
8.00 7.01 7.26 8.19 8.33 9.46 16.14 11.07 21.28 26.94 15.39
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-9.00 -0.06 -7.35 -6.31 -2.58 -10 -8.09 -6.05 -8.61 -6.59 -8.18
Operating Cash Flow to CapEx
0.00% 0.00% -38,252.38% 0.00% 0.00% 0.00% -12,576.06% 0.00% 0.00% 0.00% -34,940.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.02 0.03 0.05 0.05 0.04 0.03 0.01 0.01 0.01 0.01 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.18 0.30 0.50 0.48 0.42 0.30 0.11 0.13 0.14 0.16 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
14 5.27 6.52 6.64 6.69 6.55 7.11 3.33 4.42 1.83 -3.65
Invested Capital Turnover
0.16 0.31 0.71 0.55 0.44 0.51 0.15 0.20 0.18 0.24 0.00
Increase / (Decrease) in Invested Capital
-5.03 -16 -5.19 -7.44 -7.49 1.28 0.59 -3.31 -2.27 -4.72 -11
Enterprise Value (EV)
310 78 77 -15 -15 -13 28 152 369 323 487
Market Capitalization
424 184 167 58 46 38 114 231 460 532 684
Book Value per Share
$2.71 $2.33 $2.02 $1.67 $1.41 $1.19 $1.95 $1.30 $1.34 $2.75 $1.93
Tangible Book Value per Share
$2.71 $2.33 $2.02 $1.67 $1.41 $1.19 $1.95 $1.30 $1.34 $2.75 $1.93
Total Capital
129 111 97 80 68 57 93 82 96 211 194
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-115 -105 -90 -73 -61 -50 -86 -79 -91 -209 -197
Capital Expenditures (CapEx)
0.00 0.00 0.04 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2.11 -5.95 -3.72 -2.69 -1.81 -1.13 -0.75 -2.64 -0.92 -2.76 -7.47
Debt-free Net Working Capital (DFNWC)
117 99 86 70 59 49 85 75 90 206 189
Net Working Capital (NWC)
117 99 86 70 59 49 85 75 90 206 189
Net Nonoperating Expense (NNE)
4.47 5.48 4.13 4.93 3.63 3.34 2.55 3.23 3.89 3.84 6.27
Net Nonoperating Obligations (NNO)
-115 -105 -90 -73 -61 -50 -86 -79 -91 -209 -197
Total Depreciation and Amortization (D&A)
0.60 0.35 0.21 0.52 0.93 0.93 0.75 0.62 0.84 0.66 -0.51
Debt-free, Cash-free Net Working Capital to Revenue
77.86% -144.16% -57.79% -47.00% -39.30% -37.64% -74.60% -264.20% -91.50% -276.00% 0.00%
Debt-free Net Working Capital to Revenue
4,300.07% 2,410.26% 1,341.71% 1,228.77% 1,282.85% 1,646.28% 8,538.60% 7,542.30% 8,950.40% 20,554.30% 0.00%
Net Working Capital to Revenue
4,300.07% 2,410.26% 1,341.71% 1,228.77% 1,282.85% 1,646.28% 8,538.60% 7,542.30% 8,950.40% 20,554.30% 0.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.37) ($0.42) ($0.33) ($0.37) ($0.27) ($0.24) ($0.14) ($0.05) ($0.13) ($0.12) ($0.14)
Adjusted Weighted Average Basic Shares Outstanding
50.57M 50.79M 50.83M 50.76M 50.97M 51.00M 72.18M 69.58M 112.23M 129.78M 183.22M
Adjusted Diluted Earnings per Share
($0.37) ($0.42) ($0.33) ($0.37) ($0.27) ($0.24) ($0.14) ($0.05) ($0.13) ($0.12) ($0.14)
Adjusted Weighted Average Diluted Shares Outstanding
50.57M 50.79M 50.83M 50.76M 50.97M 51.00M 72.18M 69.58M 112.23M 129.78M 183.22M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
47.55M 47.73M 47.74M 47.90M 47.90M 47.90M 63.28M 71.56M 76.68M 100.36M 101.84M
Normalized Net Operating Profit after Tax (NOPAT)
-14 -16 -13 -14 -10 -9.12 -7.50 -9.36 -11 -11 -19
Normalized NOPAT Margin
-1,258.37% -998.97% -418.55% 0.00% 0.00% 0.00% -750.12% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
-1,659.55% -1,339.47% -556.39% 0.00% 0.00% 0.00% -1,005.60% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Shattuck Labs remains a development-stage biotechnology company with no reported revenue in the first two quarters of 2026. Revenue was intermittent in the earlier periods provided, including $3.0 million in Q3 2024 and $1.0 million in Q3 2025, but it has not yet translated into operating profitability. The company reported a $15.2 million net loss in Q2 2026, compared with losses of $14.8 million in Q1 2026 and $12.5 million in Q2 2025.

Operating expenses continue to rise as Shattuck funds its research pipeline. Q2 2026 operating expenses increased to $16.2 million from $13.0 million in Q2 2025, led by research and development spending of $11.7 million. Selling, general and administrative expense was relatively stable at $4.5 million. The higher spending reflects continued investment in development programs, but it also indicates that the company remains dependent on outside capital until it can generate recurring revenue or reach commercialization.

The balance sheet provides near-term financial flexibility. As of June 30, 2026, Shattuck held $63.3 million in cash and equivalents plus $145.0 million in short-term investments, or approximately $208.3 million in cash and liquid investments. Total liabilities were only $9.5 million, while total equity was $211.1 million. However, cash and equivalents declined from $90.4 million at the end of Q1 2026, and the company has accumulated retained losses of $460.4 million. Recent financing activity also suggests that equity issuance remains an important source of funding.

  • Strong liquidity: Cash and short-term investments totaled approximately $208.3 million at June 30, 2026, providing a substantial resource for continued research and operations.
  • Low leverage: Total liabilities of $9.5 million were modest relative to $220.7 million of total assets, limiting near-term debt-related financial risk.
  • Improved operating cash burn versus earlier periods: Q2 2026 operating cash outflow was $10.2 million, below the $16.1 million reported in Q1 2024 and the $16.7 million reported in Q3 2023.
  • Meaningful investment income: Interest and investment income increased to $1.0 million in Q2 2026 from $779,000 in Q1 2026, partially offsetting operating losses.
  • Cash runway depends on spending and investment decisions: At the Q2 operating cash-burn rate, the company’s liquid resources appear substantial, but the runway could shorten if research spending accelerates or additional capital is deployed.
  • Investment portfolio activity is significant: Shattuck purchased $144.8 million of investments in Q2 2026, while financing activities provided $128.0 million. This largely explains the quarterly decline in cash and makes reported cash movements more volatile.
  • No current revenue base: The company reported zero revenue in both Q1 and Q2 2026, leaving it dependent on its development pipeline and future partnerships or product approvals.
  • Persistent net losses: Shattuck has reported losses in every income statement period provided, with a Q2 2026 net loss of $15.2 million and accumulated retained earnings of negative $460.4 million.
  • Rising research spending: R&D expense increased from $8.7 million in Q2 2025 to $11.7 million in Q2 2026, contributing to the expansion of the operating loss.
  • Shareholder dilution risk: Common equity issuance totaled $80.7 million in Q2 2026 and $20.6 million in Q1 2026. Weighted-average basic shares rose from 51.0 million in Q2 2025 to 129.8 million in Q2 2026, which can reduce existing shareholders’ ownership and per-share upside.
11/18/26 07:09 AM ETAI Generated. May Contain Errors.

Shattuck Labs Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Shattuck Labs' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Shattuck Labs' net income appears to be on a downward trend, with a most recent value of -$48.81 million in 2025, falling from -$23.98 million in 2019. The previous period was -$75.41 million in 2024. See where experts think Shattuck Labs is headed by visiting Shattuck Labs' forecast page.

Shattuck Labs' total operating income in 2025 was -$51.51 million, based on the following breakdown:
  • Total Gross Profit: $1 million
  • Total Operating Expenses: $52.51 million

Over the last 6 years, Shattuck Labs' total revenue changed from $9.89 million in 2019 to $1 million in 2025, a change of -89.9%.

In the past 12 quarters, Shattuck Labs' cash and equivalents has ranged from $40.63 million in Q3 2023 to $90.42 million in Q1 2026, and is currently $61.76 million as of their latest financial filing in Q3 2026.

Shattuck Labs had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2019.

Over the last 6 years, Shattuck Labs' book value per share changed from -4.57 in 2019 to 1.30 in 2025.



Financial statements for NASDAQ:STTK last updated on 11/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners